A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts
A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positi...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1988 |
---|
Reproduktion: |
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 |
---|---|
Übergeordnetes Werk: |
in: Peptides - Amsterdam : Elsevier, 9(1988), 5, Seite 1059-1065 |
Übergeordnetes Werk: |
volume:9 ; year:1988 ; number:5 ; pages:1059-1065 |
Links: |
---|
Katalog-ID: |
NLEJ187003394 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ187003394 | ||
003 | DE-627 | ||
005 | 20210707063825.0 | ||
007 | cr uuu---uuuuu | ||
008 | 070506s1988 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)NLEJ187003394 | ||
035 | |a (DE-599)GBVNLZ187003394 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 2 | |a A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
264 | 1 | |c 1988 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. | ||
533 | |f Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 | ||
700 | 1 | |a Thibault, G. |4 oth | |
700 | 1 | |a Milne, R. |4 oth | |
700 | 1 | |a Cantin, M. |4 oth | |
773 | 0 | 8 | |i in |t Peptides |d Amsterdam : Elsevier |g 9(1988), 5, Seite 1059-1065 |w (DE-627)NLEJ177279168 |w (DE-600)2019194-7 |x 0196-9781 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:1988 |g number:5 |g pages:1059-1065 |
856 | 4 | 0 | |u http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 |
912 | |a GBV_USEFLAG_H | ||
912 | |a ZDB-1-SDJ | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 9 |j 1988 |e 5 |h 1059-1065 |
matchkey_str |
article:01969781:1988----::toiemuoaimtiasyfrarantirtcatrpl |
---|---|
hierarchy_sort_str |
1988 |
publishDate |
1988 |
allfields |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 DE-627 ger DE-627 rakwb eng A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts 1988 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Thibault, G. oth Milne, R. oth Cantin, M. oth in Peptides Amsterdam : Elsevier 9(1988), 5, Seite 1059-1065 (DE-627)NLEJ177279168 (DE-600)2019194-7 0196-9781 nnns volume:9 year:1988 number:5 pages:1059-1065 http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 9 1988 5 1059-1065 |
spelling |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 DE-627 ger DE-627 rakwb eng A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts 1988 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Thibault, G. oth Milne, R. oth Cantin, M. oth in Peptides Amsterdam : Elsevier 9(1988), 5, Seite 1059-1065 (DE-627)NLEJ177279168 (DE-600)2019194-7 0196-9781 nnns volume:9 year:1988 number:5 pages:1059-1065 http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 9 1988 5 1059-1065 |
allfields_unstemmed |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 DE-627 ger DE-627 rakwb eng A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts 1988 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Thibault, G. oth Milne, R. oth Cantin, M. oth in Peptides Amsterdam : Elsevier 9(1988), 5, Seite 1059-1065 (DE-627)NLEJ177279168 (DE-600)2019194-7 0196-9781 nnns volume:9 year:1988 number:5 pages:1059-1065 http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 9 1988 5 1059-1065 |
allfieldsGer |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 DE-627 ger DE-627 rakwb eng A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts 1988 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Thibault, G. oth Milne, R. oth Cantin, M. oth in Peptides Amsterdam : Elsevier 9(1988), 5, Seite 1059-1065 (DE-627)NLEJ177279168 (DE-600)2019194-7 0196-9781 nnns volume:9 year:1988 number:5 pages:1059-1065 http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 9 1988 5 1059-1065 |
allfieldsSound |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 DE-627 ger DE-627 rakwb eng A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts 1988 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Thibault, G. oth Milne, R. oth Cantin, M. oth in Peptides Amsterdam : Elsevier 9(1988), 5, Seite 1059-1065 (DE-627)NLEJ177279168 (DE-600)2019194-7 0196-9781 nnns volume:9 year:1988 number:5 pages:1059-1065 http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 9 1988 5 1059-1065 |
language |
English |
source |
in Peptides 9(1988), 5, Seite 1059-1065 volume:9 year:1988 number:5 pages:1059-1065 |
sourceStr |
in Peptides 9(1988), 5, Seite 1059-1065 volume:9 year:1988 number:5 pages:1059-1065 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
isfreeaccess_bool |
false |
container_title |
Peptides |
authorswithroles_txt_mv |
Thibault, G. @@oth@@ Milne, R. @@oth@@ Cantin, M. @@oth@@ |
publishDateDaySort_date |
1988-01-01T00:00:00Z |
hierarchy_top_id |
NLEJ177279168 |
id |
NLEJ187003394 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ187003394</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707063825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070506s1988 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ187003394</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLZ187003394</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1988</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Elsevier Journal Backfiles on ScienceDirect 1907 - 2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thibault, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milne, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cantin, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Peptides</subfield><subfield code="d">Amsterdam : Elsevier</subfield><subfield code="g">9(1988), 5, Seite 1059-1065</subfield><subfield code="w">(DE-627)NLEJ177279168</subfield><subfield code="w">(DE-600)2019194-7</subfield><subfield code="x">0196-9781</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:1988</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:1059-1065</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_H</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SDJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">1988</subfield><subfield code="e">5</subfield><subfield code="h">1059-1065</subfield></datafield></record></collection>
|
series2 |
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ177279168 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
0196-9781 |
topic_title |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
g t gt r m rm m c mc |
hierarchy_parent_title |
Peptides |
hierarchy_parent_id |
NLEJ177279168 |
hierarchy_top_title |
Peptides |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ177279168 (DE-600)2019194-7 |
title |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
spellingShingle |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
ctrlnum |
(DE-627)NLEJ187003394 (DE-599)GBVNLZ187003394 |
title_full |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
journal |
Peptides |
journalStr |
Peptides |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1988 |
contenttype_str_mv |
zzz |
container_start_page |
1059 |
container_volume |
9 |
format_se |
Elektronische Aufsätze |
title_sort |
two-site immunoradiometric assay of proatrial natriuretic factor application to tissue extracts |
title_auth |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
abstract |
A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. |
abstractGer |
A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. |
abstract_unstemmed |
A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis. |
collection_details |
GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE |
container_issue |
5 |
title_short |
A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts |
url |
http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7 |
remote_bool |
true |
author2 |
Thibault, G. Milne, R. Cantin, M. |
author2Str |
Thibault, G. Milne, R. Cantin, M. |
ppnlink |
NLEJ177279168 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
up_date |
2024-07-06T08:27:08.721Z |
_version_ |
1803817507852648448 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ187003394</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707063825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070506s1988 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ187003394</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLZ187003394</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A two-site immunoradiometric assay of proatrial natriuretic factor Application to tissue extracts</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1988</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A ''two-site'' immunoradiometric assay (IRMA) was developed to specifically measure ANF (1-126), the precursor of ANF. This assay is based on the simultaneous use of antibodies against two different antigenic determinants: murine monoclonal antibody (2H2), which recognizes positions 101 through 103 of ANF, is linked to Immunobeads and employed to extract any ANF C-terminal; a second antibody, which is directed against positions 11 through 37, is radioiodinated and allows binding to any C-terminal-2H2-Immunobead material which bears the N-terminal antigenic site. A curvilinear relationship was obtained between radioactivity and the amount of proANF (1.5 to 400 fmol) added. Optimisation of IRMA was determined by the amount of 2H2-Immunobeads and labeled antibody used, incubation time as well as possible interference by both ANF (99-126) and ANF (1-98). Tissue extracts were used to validate the assay. proANF was detected in decreasing amounts in heart atria, heart ventricles, lungs, kidneys and adrenal glands. Its presence was further confirmed by reverse-phase HPLC followed by radioimmunoassay. IRMA is a simple and rapid method for the direct measurement of proANF in tissue extracts and chromatographic fractions. The presence of proANF in tissues strongly suggests local synthesis.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Elsevier Journal Backfiles on ScienceDirect 1907 - 2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thibault, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milne, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cantin, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Peptides</subfield><subfield code="d">Amsterdam : Elsevier</subfield><subfield code="g">9(1988), 5, Seite 1059-1065</subfield><subfield code="w">(DE-627)NLEJ177279168</subfield><subfield code="w">(DE-600)2019194-7</subfield><subfield code="x">0196-9781</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:1988</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:1059-1065</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://linkinghub.elsevier.com/retrieve/pii/0196-9781(88)90089-7</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_H</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SDJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">1988</subfield><subfield code="e">5</subfield><subfield code="h">1059-1065</subfield></datafield></record></collection>
|
score |
7.3989687 |